Literature DB >> 8330569

Coexistence of neoplasia and cortical dysplasia in patients presenting with seizures.

R A Prayson1, M L Estes, H H Morris.   

Abstract

Tumors and cortical dysplasia are associated with epilepsy, but few studies have examined the coexistence of neoplasia and dysplasia in these patients. We studied 13 patients (age 4-29 years) with recurrent seizures of 1 month to 21-year' duration (median 72 months). Ten patients were aged < 21 years. Imaging studies localized the lesion to the temporal lobe (10 patients), parietal lobe (2 patients), and frontal lobe (1 patient). Tumors included ganglioglioma (8 patients), dysembryoplastic neuroepithelial tumor (DNT) (3 patients), and low-grade astrocytoma (2 patients). Cortical dysplasia, including atypical aggregates of neurons (6 patients), multifocal loss of the cortical laminar architecture (7 patients), and neurons in the molecular layer of the cortex (3 patients) were observed near but separate from the tumor. Coexistence of certain tumors with cortical dysplasia, most frequently observed in the pediatric population, suggests a hamartomatous/dysplastic nature of the neoplasms.

Entities:  

Mesh:

Year:  1993        PMID: 8330569     DOI: 10.1111/j.1528-1157.1993.tb00436.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  18 in total

1.  Comparisons of MR Findings Between Supratentorial and Infratentorial Gangliogliomas.

Authors:  X Lou; Q-P Gui; L Sun; N-Z Wu; J-H Lyu; L Ma
Journal:  Clin Neuroradiol       Date:  2014-08-23       Impact factor: 3.649

2.  Surgical outcome and prognostic factors of pediatric epilepsy caused by cortical dysplasia.

Authors:  Chul-Kee Park; Seung-Ki Kim; Kyu-Chang Wang; Yong-Seung Hwang; Ki Joong Kim; Jong Hee Chae; Je G Chi; Ghee-Young Choe; Na Rae Kim; Byung-Kyu Cho
Journal:  Childs Nerv Syst       Date:  2006-03-16       Impact factor: 1.475

3.  Survivin expression in ganglioglioma.

Authors:  Audrey Rousseau; Michèle Kujas; Anne-Marie Bergemer-Fouquet; Rémy van Effenterre; Jean-Jacques Hauw
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

4.  Dysembryoplastic neuroepithelial tumors: nonspecific histological forms -- a study of 40 cases.

Authors:  C Daumas-Duport; P Varlet; S Bacha; F Beuvon; P Cervera-Pierot; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

5.  Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity.

Authors:  J C Bartolomei; S Christopher; K Vives; D D Spencer; J M Piepmeier
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

6.  Predictors of outcome and pathological considerations in the surgical treatment of intractable epilepsy associated with temporal lobe lesions.

Authors:  M J Hennessy; R D Elwes; M Honavar; S Rabe-Hesketh; C D Binnie; C E Polkey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

7.  Advanced MR imaging of cortical dysplasia with or without neoplasm: a report of two cases.

Authors:  Jay J Pillai; Richard B Hessler; Jerry D Allison; Yong D Park; Mark R Lee; Tom Lavin
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

8.  Dysembryoplastic neuroepithelial tumor: radiological findings (including PET, SPECT, and MRS) and surgical strategy.

Authors:  D Y Lee; C K Chung; Y S Hwang; G Choe; J G Chi; H J Kim; B K Cho
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

9.  Focal cortical dysplasia with calcification: a case report.

Authors:  Kazuhiro Samura; Takato Morioka; Fumiaki Yoshida; Kimiaki Hashiguchi; Yasushi Miyagi; Masahiro Mizoguchi; Tadahisa Shono; Shinji Nagata; Satoshi O Suzuki; Tomio Sasaki
Journal:  Childs Nerv Syst       Date:  2007-12-22       Impact factor: 1.475

10.  Dysembryoplastic neuroepithelial tumors in two children with neurofibromatosis type 1.

Authors:  A Lellouch-Tubiana; M Bourgeois; M Vekemans; O Robain
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.